AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Batchelor, T Leahy, N Kaufman, D
Citation: T. Batchelor et al., High-dose methotrexate for isolated central nervous system relapse in patients with testicular non-Hodgkin's lymphoma, CLIN LYMPHO, 2(2), 2001, pp. 116-119

Authors: Jaeckle, KA Phuphanich, S van den Bent, MJ Aiken, R Batchelor, T Campbell, T Fulton, D Gilbert, M Heros, D Rogers, L O'Day, SJ Akerley, W Allen, J Baldas, S Gertler, SZ Greenberg, HS LaFollette, S Lesser, G Mason, W Recht, L Wong, E Chamberlain, MC Cohn, A Glantz, MJ Guthell, JC Maria, B Moots, P New, P Russell, C Shapiro, W Swinnen, L Howell, SB
Citation: Ka. Jaeckle et al., Intrathecal treatment of neoplastic meningitis due to breast cancer with aslow-release formulation of cytarabine, BR J CANC, 84(2), 2001, pp. 157-163

Authors: Batchelor, T Cook, EF
Citation: T. Batchelor et Ef. Cook, Clinimetric methods, PRINCIPLES OF NEUROEPIDEMIOLOGY, 2001, pp. 49-67

Authors: Batchelor, T Piscatelli, N Alderson, L
Citation: T. Batchelor et al., Brain tumors, PRINCIPLES OF NEUROEPIDEMIOLOGY, 2001, pp. 289-310

Authors: Batchelor, T
Citation: T. Batchelor, Temozolomide for malignant brain tumours, LANCET, 355(9210), 2000, pp. 1115-1116

Authors: Henson, JW Yang, J Batchelor, T
Citation: Jw. Henson et al., Intraocular methotrexate level after high-dose intravenous infusion, J CL ONCOL, 17(4), 1999, pp. 1329-1329

Authors: Glantz, MJ LaFollette, S Jaeckle, KA Shapiro, W Swinnen, L Rozental, JR Phuphanich, S Rogers, LR Gutheil, JC Batchelor, T Lyter, D Chamberlain, M Maria, BL Schiffer, C Bashir, R Thomas, D Cowens, W Howell, SB
Citation: Mj. Glantz et al., Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis, J CL ONCOL, 17(10), 1999, pp. 3110-3116

Authors: Dalmau, J Gultekin, SH Voltz, R Hoard, R DesChamps, T Balmaceda, C Batchelor, T Gerstner, E Eichen, J Frennier, J Posner, JB Rosenfeld, MR
Citation: J. Dalmau et al., Ma1, a novel neuron- and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders, BRAIN, 122, 1999, pp. 27-39
Risultati: 1-8 |